Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Phase 2

Conditions: Colorectal Neoplasms
Liver Neoplasms

Interventions: Procedure: immediate surgery (resection of primary colorectal tumor)
Drug: neo-adjuvant treatment with bevacizumab
Drug: neoadjuvant treatment with capecitabine and oxaliplatin
Drug: neo-adjuvant treatment with bevacizumab, capecitabine and oxaliplatin

First Posted Date: 2008-04-16

Last Posted Date: 2011-09-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 60

Registration Number: NCT00659022

Locations: 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
🇳🇱
The Netherlands Cancer Institute/ Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

Circulatory Changes During Venovenous (VV)- and Venoarterial (VA) Extracorporeal Membrane Oxygenation (ECMO)

Conditions: Pulmonary Hypertension of the Newborn (PPHN)

Interventions: Other: echocardiography Doppler sonography, blood and urine sampling

First Posted Date: 2008-02-25

Last Posted Date: 2008-02-25

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 30

Registration Number: NCT00622492

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

A Cluster Randomized Controlled Trial in Primary Oral Care

Early Phase 1

Completed

Conditions: Tooth, Impacted

Interventions: Behavioral: peer group educational implementation strategy

First Posted Date: 2008-02-19

Last Posted Date: 2008-02-19

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 1161

Registration Number: NCT00618215

Locations: 🇳🇱
University Medical Centre St Radboud, Nijmegen, Gelderland, Netherlands

Pharmacokinetic Study on Raltegravir and Lamotrigine

Phase 1

Completed

Conditions: HIV Infection

Interventions: Drug: lamotrigine
Drug: Raltegravir

First Posted Date: 2008-02-19

Last Posted Date: 2020-10-19

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 24

Registration Number: NCT00618241

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

Incidence of Delirium in Critically Ill Patients in a Dutch University Hospital

Completed

Conditions: Delirium

First Posted Date: 2008-01-30

Last Posted Date: 2010-08-31

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 700

Registration Number: NCT00604773

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Critical Care, Nijmegen, Gelderland, Netherlands

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Not Applicable

Completed

Conditions: Clear Cell Renal Cell Carcinoma

Interventions: Drug: Sorafenib
Drug: 111Indium-bevacizumab
Drug: 111Indium-cG250

First Posted Date: 2008-01-28

Last Posted Date: 2013-12-02

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 26

Registration Number: NCT00602862

Locations: 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands

A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes

Conditions: Myelodysplastic Syndromes (MDS)

Interventions: Other: No interventions

First Posted Date: 2008-01-25

Last Posted Date: 2020-12-30

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 4000

Registration Number: NCT00600860

Locations: 🇦🇹
University of Innsbruck Fachartz fur Innere Medizin, Dept of Hematology, Innsbruck, Austria
🇩🇪
Medizinische Klinik und Poliklinik fur Haematologie, Onkologie und Klinische Immunologie, Dusseldorf, Germany
🇨🇿
Institute of Haematology and Blood Transfusion U nemocnice, Prague, Czechia

and more 15 locations

Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients

Phase 4

Terminated

Conditions: Tumor

Interventions: Drug: Dexamethasone and Ondansetron during CE-treatment
Drug: aprepitant

First Posted Date: 2008-01-09

Last Posted Date: 2020-11-30

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT00588835

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Rituximab for Prevention of Rejection After Renal Transplantation

Phase 2

Completed

Conditions: Kidney Transplantation

Interventions: Drug: Rituximab
Drug: Placebo

First Posted Date: 2007-11-29

Last Posted Date: 2015-11-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 280

Registration Number: NCT00565331

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Lanreotide as Treatment of Polycystic Livers

Phase 2

Completed

Conditions: Polycystic Liver Disease
Hepatomegaly
Liver Diseases
Polycystic Kidney, Autosomal Dominant

Interventions: Drug: Placebo
Drug: Lanreotide

First Posted Date: 2007-11-29

Last Posted Date: 2009-02-17

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 38

Registration Number: NCT00565097

Locations: 🇧🇪
University Hospital Gasthuisberg, Leuven, Belgium
🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy